1. Simonds RJ, Oxtoby MJ, Caldwell MB, Gwinn ML, Rogers ML. Pneumocystis carinii pneumonia among U.S. children with perinatally acquired HIV infection. JAMA 1993;270:470-3.


2. Gibb DM, Davison CF, Holland FJ, Walters S, Novelli V, Mok J. Pneumocystic carinii pneumonia in vertically acquired HIV infection in the British Isles. Arch Dis Child 1994;70:241-4.


3. Centers for Disease Control and Prevention. Guidelines for prophylaxis against pneumocystis carinii pneumonia for children infected with human immunodeficiency varus. MMWR 1991;40 (RR-2).


4. Stringer JR, Beard CB, Miller RF, Wakefield AE. A new name (Pneumocystis Siroveci) for Pneumolcystis from humans. Emerg Infect Dis 2002;8:891-6.


5. Vargas SL, Hughes WT, Santolaya ME et al. Search for primary infection by pneumolcystis carinii in a cohort of normal, healthy infants. Clin Infect Dis 2001;32:855-61.


6. Mofenson LM, Oleske J, Serchuck L, Dyke RV, Wilfert C, Treating Opportunistic Infectious among HIV-exposed and infected children: Recommendations from CDC, the National Institutes of Health, and the Infections Diseases Society of America. CID 2005:40 (Suppl 1);S1-S84.


7. Manual for Management of HIV/AIDS in children. NACO, IAP, WHO, UNICEF. 2004;47-66.
8. Hughes WT. Pneumolcystis carinii pneumonia: new approaches to diagnosis, treatment and prevention. Pediatr Infect Dis J 1991;10:391-399.


9. Gutman LT. The use of trimethoprim-sulfamethoxazole in children : a review of adverse reactions and indications. Pediatr Infect Dis 1984;3:349-357.


10. Rieder MJ, King SM, Read S. Adverse reactions to trimethoprim-sulfamethoxazole among children with human immunodeficiency virus infection. Pediatr Infect Dis J 1997;16:1028-31.


11. Goodwin SD. Pneumolcystis carinii pneumonia in human immunodeficiency virus-infected infants and children. Pharmacotherapy 1993;13:640-6.


12. Hughes W, Dorenbaum A, Yogev R et al. Phase I safety and pharmacokinetics study of micronized atovaguone in human immunodeficiency virus-infected infants and children. Antimicrob Agents Chemother 1998;42:1315-8.


13. Shah I. AGE RELATED CLINICAL MANIFESTATIONS OF HIV INFECTION IN INDIAN CHILDREN. Journal of Tropical Pediatrics. Advance Access published June 24, 2005


14. Coovadia HM, Jeena P, Wilkinson D. Childhood human immunodeficiency virus and tuberculosis. Co-infection: reconciling conflicting data. Int J Tuberc Lung Dis 1998;2:844-51.


15. Jeena PM, Pillay P, Pillay T, Coovadia HM. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa. Int J Tuberc Lung Dis 2002;6:672-8.
16. Bakshi SS, Alvarez D, Hilfer CL, Sondillo EM et al. Tuberculosis in human immunodeficiency virus-infected children: a family infection. Am J Dis Child 1993;147:320-4.


17. Starke JR. Disgnosis of tuberculosis in children. Pediatr Infect Dis J 2000;19:1095-6.


18. Delacourt C, Proveda JD, Churean C, et al. Use of polymerase chain reaction for improved diagnosis of tuberculosis in children. J Pediatr 1995;126:703-9.


19. Pierre C, Olivier C, Lecossier D, et al. Diagnosis of primary tuberculosis in children by amplification and detection of mycobacterial DNA. Am Rev Respn Dis 1993;147:420-4.


20. Smith K, Starke J, Eisenach K, Ong L, Denby M. Detection of mycobacterium tuberculosis in clinical specimens from children using a polymerase chain reaction. Pediatrics 1996:97:155-60.


21. IAP-consensus statement for Tuberculosis